FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jonathan Katz

Research Profile

Chemicals & Drugs

Living Beings

Concepts & Ideas

Drug Dose Response Relationship

Activities & Behaviors

Motor Activity

Physiology

Procedures

Radioligand Assay

Co-author Network

Publications

TOP 3
Takato Hiranita; Maddalena Mereu; Paul Levi Soto; Gianluigi Tanda; Jonathan L Katz
Self-administration of cocaine induces dopamine-independent self-administration of sigma agonists.
Libin Li; Amy Hauck Newman; Shuichiro Hayashi; Takato Hiranita; Jonathan L Katz
The stereotypy-inducing effects of N-substituted benztropine analogs alone and in combination with cocaine do not account for their blockade of cocaine self-administration.
Claus Loland; Sonia Mazier; Maddalena Mereu; Oluyomi M Okunola; Thomas E Prisinzano; Lei Shi; Gianluigi Tanda; Jianjing Cao; Jonathan L Katz; Theresa A Kopajtic; Amy Hauck Newman
R-modafinil (armodafinil): a unique dopamine uptake inhibitor and potential medication for psychostimulant abuse.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jonathan Katz (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Takato Hiranita; Maddalena Mereu; Paul Levi Soto; Gianluigi Tanda; Jonathan L Katz
Self-administration of cocaine induces dopamine-independent self-administration of sigma agonists.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2013;38(4):605-15.
2013: Libin Li; Amy Hauck Newman; Shuichiro Hayashi; Takato Hiranita; Jonathan L Katz
The stereotypy-inducing effects of N-substituted benztropine analogs alone and in combination with cocaine do not account for their blockade of cocaine self-administration.
Psychopharmacology 2013;225(3):733-42.
2012: Claus Loland; Sonia Mazier; Maddalena Mereu; Oluyomi M Okunola; Thomas E Prisinzano; Lei Shi; Gianluigi Tanda; Jianjing Cao; Jonathan L Katz; Theresa A Kopajtic; Amy Hauck Newman
R-modafinil (armodafinil): a unique dopamine uptake inhibitor and potential medication for psychostimulant abuse.
Biological psychiatry 2012;72(5):405-13.
2011: Takato Hiranita; Jianjing Cao; Stephen J Kohut; Theresa A Kopajtic; Amy Hauck Newman; Paul Levi Soto; Gianluigi Tanda; Jonathan L Katz
Decreases in cocaine self-administration with dual inhibition of the dopamine transporter and σ receptors.
The Journal of pharmacology and experimental therapeutics 2011;339(2):662-77.
2011: Su-Min Li; Theresa A Kopajtic; Matthew J O'Callaghan; Gregory E Agoston; Jianjing Cao; Amy Hauck Newman; Jonathan L Katz
N-substituted benztropine analogs: selective dopamine transporter ligands with a fast onset of action and minimal cocaine-like behavioral effects.
The Journal of pharmacology and experimental therapeutics 2011;336(2):575-85.
2011: Linda Garcés-Ramírez; Jennifer L Green; Takato Hiranita; Theresa A Kopajtic; Maddalena Mereu; Alexandra M Thomas; Christophe Mesangeau; Sanju Narayanan; Christopher R McCurdy; Jonathan L Katz; Gianluigi Tanda
Sigma receptor agonists: receptor binding and effects on mesolimbic dopamine neurotransmission assessed by microdialysis.
Biological psychiatry 2011;69(3):208-17.
2010: Theresa A Kopajtic; Yi Liu; Christopher K Surratt; David M Donovan; Amy Hauck Newman; Jonathan L Katz
Dopamine transporter-dependent and -independent striatal binding of the benztropine analog JHW 007, a cocaine antagonist with low abuse liability.
The Journal of pharmacology and experimental therapeutics 2010;335(3):703-14.
2010: Peng Zhang; George Cyriac; Theresa A Kopajtic; Yongfang Zhao; Jonathan A Javitch; Jonathan L Katz; Amy Hauck Newman
Structure-activity relationships for a novel series of citalopram (1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile) analogues at monoamine transporters.
Journal of medicinal chemistry 2010;53(16):6112-21.
2010: Su-Min Li; Gregory Collins; Noel M Paul; Peter Grundt; Amy Hauck Newman; Ming Xu; David K Grandy; James H Woods; Jonathan L Katz
Yawning and locomotor behavior induced by dopamine receptor agonists in mice and rats.
Behavioural pharmacology 2010;21(3):171-81.
2010: Takato Hiranita; Paul Levi Soto; Gianluigi Tanda; Jonathan L Katz
Reinforcing effects of sigma-receptor agonists in rats trained to self-administer cocaine.
The Journal of pharmacology and experimental therapeutics 2010;332(2):515-24.
2009: Gianluigi Tanda; Amy Hauck Newman; Aaron L Ebbs; Valeria Tronci; Jennifer L Green; Ronald J Tallarida; Jonathan L Katz
Combinations of cocaine with other dopamine uptake inhibitors: assessment of additivity.
The Journal of pharmacology and experimental therapeutics 2009;330(3):802-9.
2009: Takato Hiranita; Paul Levi Soto; Amy Hauck Newman; Jonathan L Katz
Assessment of reinforcing effects of benztropine analogs and their effects on cocaine self-administration in rats: comparisons with monoamine uptake inhibitors.
The Journal of pharmacology and experimental therapeutics 2009;329(2):677-86.
2009: Paul Levi Soto; Jonathan L Katz
Fluoxetine does not alter the ability of dopamine D(1)- and D(2)-like agonists to substitute for cocaine in squirrel monkeys.
Pharmacology, biochemistry, and behavior 2009;92(2):219-23.
2009: Gianluigi Tanda; Amy H Newman; Jonathan L Katz
Discovery of drugs to treat cocaine dependence: behavioral and neurochemical effects of atypical dopamine transport inhibitors.
Advances in pharmacology (San Diego, Calif.) 2009;57():253-89.
2008: Jianjing Cao; Theresa A Kopajtic; Jonathan L Katz; Amy Hauck Newman
Dual DAT/sigma1 receptor ligands based on 3-(4-(3-(bis(4-fluorophenyl)amino)propyl)piperazin-1-yl)-1-phenylpropan-1-ol.
Bioorganic & medicinal chemistry letters 2008;18(19):5238-41.
2008: Gianluigi Tanda; Theresa A Kopajtic; Jonathan L Katz
Cocaine-like neurochemical effects of antihistaminic medications.
Journal of neurochemistry 2008;106(1):147-57.
2008: Claus Loland; Rajeev I Desai; Mu-Fa Zou; Jianjing Cao; Peter Grundt; Klaus Gerstbrein; Harald H Sitte; Amy Hauck Newman; Jonathan L Katz; Ulrik Gether
Relationship between conformational changes in the dopamine transporter and cocaine-like subjective effects of uptake inhibitors.
Molecular pharmacology 2008;73(3):813-23.
2007: Gianluigi Tanda; Jonathan L Katz
Muscarinic preferential M(1) receptor antagonists enhance the discriminative-stimulus effects of cocaine in rats.
Pharmacology, biochemistry, and behavior 2007;87(4):400-4.
2007: Gianluigi Tanda; Aaron L Ebbs; Theresa A Kopajtic; Lyn M Elias; Bettye L Campbell; Amy Hauck Newman; Jonathan L Katz
Effects of muscarinic M1 receptor blockade on cocaine-induced elevations of brain dopamine levels and locomotor behavior in rats.
The Journal of pharmacology and experimental therapeutics 2007;321(1):334-44.
2006: Amy Hauck Newman; Joo Hwan Cha; Jianjing Cao; Theresa A Kopajtic; Jonathan L Katz; M Laura Parnas; Roxanne Vaughan; John R Lever
Design and synthesis of a novel photoaffinity ligand for the dopamine and serotonin transporters based on 2beta-carbomethoxy-3beta-biphenyltropane.
Journal of medicinal chemistry 2006;49(22):6621-5.
2006: Mu-Fa Zou; Jianjing Cao; Theresa A Kopajtic; Rajeev I Desai; Jonathan L Katz; Amy Hauck Newman
Structure-activity relationship studies on a novel series of (S)-2beta-substituted 3alpha-[bis(4-fluoro- or 4-chlorophenyl)methoxy]tropane analogues for in vivo investigation.
Journal of medicinal chemistry 2006;49(21):6391-9.
2006: Jonathan L Katz; Theresa A Kopajtic; Philip Terry
Effects of dopamine D1-like receptor agonists on food-maintained operant behavior in rats.
Behavioural pharmacology 2006;17(4):303-9.
2006: Su-Min Li; Bettye L Campbell; Jonathan L Katz
Interactions of cocaine with dopamine uptake inhibitors or dopamine releasers in rats discriminating cocaine.
The Journal of pharmacology and experimental therapeutics 2006;317(3):1088-96.
2006: Santosh S Kulkarni; Theresa A Kopajtic; Jonathan L Katz; Amy Hauck Newman
Comparative structure-activity relationships of benztropine analogues at the dopamine transporter and histamine H(1) receptors.
Bioorganic & medicinal chemistry 2006;14(11):3625-34.
2005: Peter Grundt; Theresa A Kopajtic; Jonathan L Katz; Amy Hauck Newman
N-8-Substituted benztropinamine analogs as selective dopamine transporter ligands.
Bioorganic & medicinal chemistry letters 2005;15(24):5419-23.
2005: Vera C Campbell; Theresa A Kopajtic; Amy Hauck Newman; Jonathan L Katz
Assessment of the influence of histaminergic actions on cocaine-like effects of 3alpha-diphenylmethoxytropane analogs.
The Journal of pharmacology and experimental therapeutics 2005;315(2):631-40.
2005: Rajeev I Desai; Theresa A Kopajtic; Dawn French; Amy Hauck Newman; Jonathan L Katz
Relationship between in vivo occupancy at the dopamine transporter and behavioral effects of cocaine, GBR 12909 [1-{2-[bis-(4-fluorophenyl)methoxy]ethyl}-4-(3-phenylpropyl)piperazine], and benztropine analogs.
The Journal of pharmacology and experimental therapeutics 2005;315(1):397-404.
2005: Rajeev I Desai; Philip Terry; Jonathan L Katz
A comparison of the locomotor stimulant effects of D1-like receptor agonists in mice.
Pharmacology, biochemistry, and behavior 2005;81(4):843-8.
2005: Su-Min Li; Amy Hauck Newman; Jonathan L Katz
Place conditioning and locomotor effects of N-substituted, 4',4''-difluorobenztropine analogs in rats.
The Journal of pharmacology and experimental therapeutics 2005;313(3):1223-30.
2005: Gianluigi Tanda; Aaron Ebbs; Amy Hauck Newman; Jonathan L Katz
Effects of 4'-chloro-3 alpha-(diphenylmethoxy)-tropane on mesostriatal, mesocortical, and mesolimbic dopamine transmission: comparison with effects of cocaine.
The Journal of pharmacology and experimental therapeutics 2005;313(2):613-20.
2005: Stacey A Lomenzo; Jill B Rhoden; Sari Izenwasser; Dean Wade; Theresa A Kopajtic; Jonathan L Katz; Mark L Trudell
Synthesis and biological evaluation of meperidine analogues at monoamine transporters.
Journal of medicinal chemistry 2005;48(5):1336-43.
2005: Rajeev I Desai; Theresa A Kopajtic; Mikhail Koffarnus; Amy Hauck Newman; Jonathan L Katz
Identification of a dopamine transporter ligand that blocks the stimulant effects of cocaine.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2005;25(8):1889-93.
2005: Leigh V Panlilio; Sevil Yasar; Ro Nemeth-Coslett; Jonathan L Katz; Jack E Henningfield; Marcello Solinas; STEPHEN HEISHMAN; Charles W Schindler; Steven R Goldberg
Human cocaine-seeking behavior and its control by drug-associated stimuli in the laboratory.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2005;30(2):433-43.
2004: Jianjing Cao; John R Lever; Theresa A Kopajtic; Jonathan L Katz; Anh T Pham; Muhsinah L Holmes; Joseph B Justice; Amy Hauck Newman
Novel azido and isothiocyanato analogues of [3-(4-phenylalkylpiperazin-1-yl)propyl]bis(4-fluorophenyl)amines as potential irreversible ligands for the dopamine transporter.
Journal of medicinal chemistry 2004;47(25):6128-36.
2004: Peter Grundt; Theresa A Kopajtic; Jonathan L Katz; Amy Hauck Newman
The effect of 6-substituted-4',4"-difluorobenztropines on monoamine transporters and the muscarinic M1 receptor.
Bioorganic & medicinal chemistry letters 2004;14(12):3295-8.
2004: Santosh S Kulkarni; Peter Grundt; Theresa A Kopajtic; Jonathan L Katz; Amy Hauck Newman
Structure-activity relationships at monoamine transporters for a series of N-substituted 3alpha-(bis[4-fluorophenyl]methoxy)tropanes: comparative molecular field analysis, synthesis, and pharmacological evaluation.
Journal of medicinal chemistry 2004;47(13):3388-98.
2004: Jonathan L Katz; Theresa A Kopajtic; Gregory E Agoston; Amy Hauck Newman
Effects of N-substituted analogs of benztropine: diminished cocaine-like effects in dopamine transporter ligands.
The Journal of pharmacology and experimental therapeutics 2004;309(2):650-60.
2004: Lifen Xu; Santosh S Kulkarni; Sari Izenwasser; Jonathan L Katz; Theresa A Kopajtic; Stacey A Lomenzo; Amy Hauck Newman; Mark L Trudell
Synthesis and monoamine transporter binding of 2-(diarylmethoxymethyl)-3 beta-aryltropane derivatives.
Journal of medicinal chemistry 2004;47(7):1676-82.
2003: Jonathan L Katz; Allison L Chausmer; Gregory I Elmer; Marcelo Rubinstein; Malcolm J Low; David K Grandy
Cocaine-induced locomotor activity and cocaine discrimination in dopamine D4 receptor mutant mice.
Psychopharmacology 2003;170(1):108-14.
2003: Mu-Fa Zou; Theresa A Kopajtic; Jonathan L Katz; Amy Hauck Newman
Structure-activity relationship comparison of (S)-2beta-substituted 3alpha-(bis[4-fluorophenyl]methoxy)tropanes and (R)-2beta-substituted 3beta-(3,4-dichlorophenyl)tropanes at the dopamine transporter.
Journal of medicinal chemistry 2003;46(14):2908-16.
2003: Jonathan L Katz; Stephen T Higgins
The validity of the reinstatement model of craving and relapse to drug use.
Psychopharmacology 2003;168(1-2):21-30.
2003: Jianjing Cao; Santosh S Kulkarni; Stephen M Husbands; Wayne D Bowen; Wanda Williams; Theresa A Kopajtic; Jonathan L Katz; Clifford George; Amy Hauck Newman
Dual probes for the dopamine transporter and sigma1 receptors: novel piperazinyl alkyl-bis(4'-fluorophenyl)amine analogues as potential cocaine-abuse therapeutic agents.
Journal of medicinal chemistry 2003;46(13):2589-98.
2003: Jonathan L Katz; Therissa A Libby; Theresa A Kopajtic; Stephen M Husbands; Amy Hauck Newman
Behavioral effects of rimcazole analogues alone and in combination with cocaine.
European journal of pharmacology 2003;468(2):109-19.
2003: Rajeev I Desai; Philip Terry; Jonathan L Katz
Comparison of the discriminative-stimulus effects of SKF 38393 with those of other dopamine receptor agonists.
Behavioural pharmacology 2003;14(3):223-8.
2003: Leigh V Panlilio; Jonathan L Katz; Roy W Pickens; Charles W Schindler
Variability of drug self-administration in rats.
Psychopharmacology 2003;167(1):9-19.
2002: Allison L Chausmer; Gregory I Elmer; Marcelo Rubinstein; Malcolm J Low; David K Grandy; Jonathan L Katz
Cocaine-induced locomotor activity and cocaine discrimination in dopamine D2 receptor mutant mice.
Psychopharmacology 2002;163(1):54-61.
2002: Mu-Fa Zou; Gregory E Agoston; Yuri Belov; Theresa A Kopajtic; Jonathan L Katz; Amy Hauck Newman
Enantioselective synthesis of S-(+)-2beta-carboalkoxy-3alpha-[bis(4-fluorophenyl)methoxy]tropanes as novel probes for the dopamine transporter.
Bioorganic & medicinal chemistry letters 2002;12(9):1249-52.
2002: Lifen Xu; Sari Izenwasser; Jonathan L Katz; Theresa A Kopajtic; Cheryl Klein-Stevens; Naiju Zhu; Stacey A Lomenzo; Leyte Winfield; Mark L Trudell
Synthesis and biological evaluation of 2-substituted 3beta-tolyltropane derivatives at dopamine, serotonin, and norepinephrine transporters.
Journal of medicinal chemistry 2002;45(6):1203-10.
2002: Allison L Chausmer; Jonathan L Katz
Comparison of interactions of D1-like agonists, SKF 81297, SKF 82958 and A-77636, with cocaine: locomotor activity and drug discrimination studies in rodents.
Psychopharmacology 2002;159(2):145-53.
2001: Jianjing Cao; Stephen M Husbands; Theresa A Kopajtic; Jonathan L Katz; Amy Hauck Newman
[3-cis-3,5-Dimethyl-(1-piperazinyl)alkyl]-bis-(4'-fluorophenyl)amine analogues as novel probes for the dopamine transporter.
Bioorganic & medicinal chemistry letters 2001;11(24):3169-73.
2001: Mu-Fa Zou; Theresa A Kopajtic; Jonathan L Katz; Sara E Wirtz; Joseph B Justice; Amy Hauck Newman
Novel tropane-based irreversible ligands for the dopamine transporter.
Journal of medicinal chemistry 2001;44(25):4453-61.
2001: Allison L Chausmer; Jonathan L Katz
The role of D2-like dopamine receptors in the locomotor stimulant effects of cocaine in mice.
Psychopharmacology 2001;155(1):69-77.
2001: William L Woolverton; G S Hecht; Gregory E Agoston; Jonathan L Katz; Amy Hauck Newman
Further studies of the reinforcing effects of benztropine analogs in rhesus monkeys.
Psychopharmacology 2001;154(4):375-82.
2001: Jonathan L Katz; Gregory E Agoston; KL Alling; RH Kline; M J Forster; William L Woolverton; Theresa A Kopajtic; Amy Hauck Newman
Dopamine transporter binding without cocaine-like behavioral effects: synthesis and evaluation of benztropine analogs alone and in combination with cocaine in rodents.
Psychopharmacology 2001;154(4):362-74.
2001: Amy Hauck Newman; Michael J Robarge; I M Howard; S L Wittkopp; Clifford George; Theresa A Kopajtic; Sari Izenwasser; Jonathan L Katz
Structure-activity relationships at monoamine transporters and muscarinic receptors for N-substituted-3alpha-(3'-chloro-, 4'-chloro-, and 4',4''-dichloro-substituted-diphenyl)methoxytropanes.
Journal of medicinal chemistry 2001;44(4):633-40.
2000: B T Hoffman; Theresa A Kopajtic; Jonathan L Katz; Amy Hauck Newman
2D QSAR modeling and preliminary database searching for dopamine transporter inhibitors using genetic algorithm variable selection of Molconn Z descriptors.
Journal of medicinal chemistry 2000;43(22):4151-9.
2000: Jonathan L Katz; KL Alling
Discriminative stimulus effects of putative D3 dopamine receptor agonists in rats.
Behavioural pharmacology 2000;11(6):483-93.
2000: Michael J Robarge; Gregory E Agoston; Sari Izenwasser; Theresa A Kopajtic; Clifford George; Jonathan L Katz; Amy Hauck Newman
Highly selective chiral N-substituted 3alpha-[bis(4'-fluorophenyl)methoxy]tropane analogues for the dopamine transporter: synthesis and comparative molecular field analysis.
Journal of medicinal chemistry 2000;43(6):1085-93.
2000: William L Woolverton; James K Rowlett; KM Wilcox; Ian A Paul; RH Kline; Amy Hauck Newman; Jonathan L Katz
3'- and 4'-chloro-substituted analogs of benztropine: intravenous self-administration and in vitro radioligand binding studies in rhesus monkeys.
Psychopharmacology 2000;147(4):426-35.
2000: Jonathan L Katz; Sari Izenwasser; Philip Terry
Relationships among dopamine transporter affinities and cocaine-like discriminative-stimulus effects.
Psychopharmacology 2000;148(1):90-8.
1999: Stacey A Lomenzo; Sari Izenwasser; R M Gerdes; Jonathan L Katz; Theresa A Kopajtic; Mark L Trudell
Synthesis, dopamine and serotonin transporter binding affinities of novel analogues of meperidine.
Bioorganic & medicinal chemistry letters 1999;9(23):3273-6.
1999: Stephen M Husbands; Sari Izenwasser; Theresa A Kopajtic; Wayne D Bowen; BJ Vilner; Jonathan L Katz; Amy Hauck Newman
Structure-activity relationships at the monoamine transporters and sigma receptors for a novel series of 9-[3-(cis-3, 5-dimethyl-1-piperazinyl)propyl]carbazole (rimcazole) analogues.
Journal of medicinal chemistry 1999;42(21):4446-55.
1999: Jonathan L Katz; Sari Izenwasser; RH Kline; A C Allen; Amy Hauck Newman
Novel 3alpha-diphenylmethoxytropane analogs: selective dopamine uptake inhibitors with behavioral effects distinct from those of cocaine.
The Journal of pharmacology and experimental therapeutics 1999;288(1):302-15.
1998: Chunming Zhang; Sari Izenwasser; Jonathan L Katz; P D Terry; Mark L Trudell
Synthesis and dopamine transporter affinity of the four stereoisomers of (+/-)-2-(methoxycarbonyl)-7-methyl-3-phenyl-7-azabicyclo[2.2.1]heptane.
Journal of medicinal chemistry 1998;41(13):2430-5.
1997: Stacey A Lomenzo; Sari Izenwasser; Jonathan L Katz; P D Terry; Naiju Zhu; C L Klein; Mark L Trudell
Synthesis, structure, dopamine transporter affinity, and dopamine uptake inhibition of 6-alkyl-3-benzyl-2-[(methoxycarbonyl)methyl]tropane derivatives.
Journal of medicinal chemistry 1997;40(26):4406-14.
1997: Stephen M Husbands; Sari Izenwasser; RJ Loeloff; Jonathan L Katz; Wayne D Bowen; BJ Vilner; Amy Hauck Newman
Isothiocyanate derivatives of 9-[3-(cis-3,5-dimethyl-1-piperazinyl)propyl]carbazole (rimcazole): irreversible ligands for the dopamine transporter.
Journal of medicinal chemistry 1997;40(26):4340-46.
1997: Philip Terry; Jonathan L Katz
Dopaminergic mediation of the discriminative stimulus effects of bupropion in rats.
Psychopharmacology 1997;134(2):201-12.
1997: Beth Geter-Douglass; Jonathan L Katz; KL Alling; JB Acri; Jeffrey M Witkin
Characterization of unconditioned behavioral effects of dopamine D3/D2 receptor agonists.
The Journal of pharmacology and experimental therapeutics 1997;283(1):7-15.
1997: Jonathan L Katz; Amy Hauck Newman; Sari Izenwasser
Relations between heterogeneity of dopamine transporter binding and function and the behavioral pharmacology of cocaine.
Pharmacology, biochemistry, and behavior 1997;57(3):505-12.
1997: Lifen Xu; S V Kelkar; Stacey A Lomenzo; Sari Izenwasser; Jonathan L Katz; RH Kline; Mark L Trudell
Synthesis, dopamine transporter affinity, dopamine uptake inhibition, and locomotor stimulant activity of 2-substituted 3 beta-phenyltropane derivatives.
Journal of medicinal chemistry 1997;40(6):858-63.
1997: RH Kline; Sari Izenwasser; Jonathan L Katz; D B Joseph; Wayne D Bowen; Amy Hauck Newman
3'-Chloro-3 alpha-(diphenylmethoxy)tropane but not 4'-chloro-3 alpha-(diphenylmethoxy)tropane produces a cocaine-like behavioral profile.
Journal of medicinal chemistry 1997;40(6):851-7.
1996: Z Chen; Sari Izenwasser; Jonathan L Katz; N Zhu; C L Klein; Mark L Trudell
Synthesis and dopamine transporter affinity of 2-(methoxycarbonyl)-9-methyl-3-phenyl-9-azabicyclo[3.3.1]nonane derivatives.
Journal of medicinal chemistry 1996;39(24):4744-9.
1996: B Aronson; J L Enmon; Sari Izenwasser; Jonathan L Katz; S V Kelkar; L Luo; S P Nolan; Mark L Trudell
Synthesis and ligand binding of eta(6)-(2beta-carbomethoxy-3beta-phenyltropane) transition metal complexes.
Journal of medicinal chemistry 1996;39(7):1560-3.
1996: Sari Izenwasser; Amy Hauck Newman; B M Cox; Jonathan L Katz
The cocaine-like behavioral effects of meperidine are mediated by activity at the dopamine transporter.
European journal of pharmacology 1996;297(1-2):9-17.
1995: Amy Hauck Newman; RH Kline; A C Allen; Sari Izenwasser; C George; Jonathan L Katz
Novel 4'-substituted and 4',4"-disubstituted 3 alpha-(diphenylmethoxy)tropane analogs as potent and selective dopamine uptake inhibitors.
Journal of medicinal chemistry 1995;38(20):3933-40.
1995: JB Acri; S R Carter; K Alling; Beth Geter-Douglass; Durk Dijkstra; H Wikström; Jonathan L Katz; Jeffrey M Witkin
Assessment of cocaine-like discriminative stimulus effects of dopamine D3 receptor ligands.
European journal of pharmacology 1995;281(2):R7-9.
1995: Ricardo Pellón; Pilar Flores; K Alling; Jeffrey M Witkin; Jonathan L Katz
Pharmacological analysis of the scratching produced by dopamine D2 agonists in squirrel monkeys.
The Journal of pharmacology and experimental therapeutics 1995;273(1):138-45.
1994: S V Kelkar; Sari Izenwasser; Jonathan L Katz; C L Klein; N Zhu; Mark L Trudell
Synthesis, cocaine receptor affinity, and dopamine uptake inhibition of several new 2 beta-substituted 3 beta-phenyltropanes.
Journal of medicinal chemistry 1994;37(23):3875-7.
1994: Sari Izenwasser; P Terry; B Heller; Jeffrey M Witkin; Jonathan L Katz
Differential relationships among dopamine transporter affinities and stimulant potencies of various uptake inhibitors.
European journal of pharmacology 1994;263(3):277-83.
1994: P Terry; Jeffrey M Witkin; Jonathan L Katz
Pharmacological characterization of the novel discriminative stimulus effects of a low dose of cocaine.
The Journal of pharmacology and experimental therapeutics 1994;270(3):1041-8.
1994: Amy Hauck Newman; A C Allen; Sari Izenwasser; Jonathan L Katz
Novel 3 alpha-(diphenylmethoxy)tropane analogs: potent dopamine uptake inhibitors without cocaine-like behavioral profiles.
Journal of medicinal chemistry 1994;37(15):2258-61.
1994: J I Székely; Lawrence G Sharpe; Jonathan L Katz
Effects of caramiphen and phencyclidine alone and in combination on behavior in the rat.
Pharmacology, biochemistry, and behavior 1994;47(3):709-13.
1994: Sari Izenwasser; Jonathan L Katz
7-OH-DPAT antagonizes dopamine D2 receptor-inhibited adenylyl cyclase activity.
Life sciences 1994;55(14):PL257-9.
1994: P Terry; Jonathan L Katz
A comparison of the effects of the D1 receptor antagonists SCH 23390 and SCH 39166 on suppression of feeding behavior by the D1 agonist SKF38393.
Psychopharmacology 1994;113(3-4):328-33.
1993: Sari Izenwasser; Amy Hauck Newman; Jonathan L Katz
Cocaine and several sigma receptor ligands inhibit dopamine uptake in rat caudate-putamen.
European journal of pharmacology 1993;243(2):201-5.
1993: Jeffrey M Witkin; Amy Hauck Newman; G Nowak; Jonathan L Katz
Role of dopamine D1 receptors in the lethal effects of cocaine and a quaternary methiodide analog.
The Journal of pharmacology and experimental therapeutics 1993;267(1):266-74.
1993: Jeffrey M Witkin; P Terry; M Menkel; P Hickey; M Pontecorvo; J Ferkany; Jonathan L Katz
Effects of the selective sigma receptor ligand, 6-[6-(4-hydroxypiperidinyl)hexyloxy]-3-methylflavone (NPC 16377), on behavioral and toxic effects of cocaine.
The Journal of pharmacology and experimental therapeutics 1993;266(2):473-82.
1993: Sari Izenwasser; Jonathan L Katz
Differential efficacies of dopamine D1 receptor agonists for stimulating adenylyl cyclase in squirrel monkey and rat.
European journal of pharmacology 1993;246(1):39-44.
1993: Jonathan L Katz; J W Griffiths; Lawrence G Sharpe; E B De Souza; Jeffrey M Witkin
Cocaine tolerance and cross-tolerance.
The Journal of pharmacology and experimental therapeutics 1993;264(1):183-92.
1993: Charles W Schindler; Steven R Goldberg; Jonathan L Katz
Pharmacological specificity of enhanced sensitivity to naltrexone in rats.
Psychopharmacology 1993;110(1-2):60-8.
1993: Jonathan L Katz; Jeffrey M Witkin
Behavioral effects of dopaminergic agonists and antagonists alone and in combination in the squirrel monkey.
Psychopharmacology 1993;113(1):19-25.
1992: K Takada; J E Barrett; M S Allen; James M Cook; Jonathan L Katz
Punishment of schedule-controlled behavior with beta-carboline injections: antagonism and comparisons with other compounds.
The Journal of pharmacology and experimental therapeutics 1992;261(1):138-45.
1992: Charles W Schindler; Srihari R Tella; Jonathan L Katz; Steven R Goldberg
Effects of cocaine and its quaternary derivative cocaine methiodide on cardiovascular function in squirrel monkeys.
European journal of pharmacology 1992;213(1):99-105.
1992: E J Cline; Ursula Scheffel; J W Boja; Frank carroll; Jonathan L Katz; Michael J Kuhar
Behavioral effects of novel cocaine analogs: a comparison with in vivo receptor binding potency.
The Journal of pharmacology and experimental therapeutics 1992;260(3):1174-9.
1992: Jonathan L Katz; George A Ricaurte; Jeffrey M Witkin
Reinforcing effects of enantiomers of N,N-dimethylamphetamine in squirrel monkeys.
Psychopharmacology 1992;107(2-3):315-8.
1992: Jonathan L Katz; P Terry; Jeffrey M Witkin
Comparative behavioral pharmacology and toxicology of cocaine and its ethanol-derived metabolite, cocaine ethyl-ester (cocaethylene).
Life sciences 1992;50(18):1351-61.
1992: P Terry; Jonathan L Katz
Differential antagonism of the effects of dopamine D1-receptor agonists on feeding behavior in the rat.
Psychopharmacology 1992;109(4):403-9.
1992: Jonathan L Katz; Jeffrey M Witkin
Selective effects of the D1 dopamine receptor agonist, SKF 38393, on behavior maintained by cocaine injection in squirrel monkeys.
Psychopharmacology 1992;109(1-2):241-4.
1992: Jonathan L Katz; Jeffrey M Witkin
Effects of quinpirole and SKF 38393 alone and in combination in squirrel monkeys trained to discriminate cocaine.
Psychopharmacology 1992;107(2-3):217-20.
1991: Richard J Lamb; Kenzie L. Preston; Charles W Schindler; Richard A Meisch; Faith G Davis; Jonathan L Katz; Jack E Henningfield; Steven R Goldberg
The reinforcing and subjective effects of morphine in post-addicts: a dose-response study.
The Journal of pharmacology and experimental therapeutics 1991;259(3):1165-73.
1991: M Menkel; P Terry; M Pontecorvo; Jonathan L Katz; Jeffrey M Witkin
Selective sigma ligands block stimulant effects of cocaine.
European journal of pharmacology 1991;201(2-3):251-2.
1991: Jeffrey M Witkin; D E Nichols; P Terry; Jonathan L Katz
Behavioral effects of selective dopaminergic compounds in rats discriminating cocaine injections.
The Journal of pharmacology and experimental therapeutics 1991;257(2):706-13.
1991: Jeffrey M Witkin; Rolley E. Johnson; Jerome H Jaffe; Steven R Goldberg; N A Grayson; Kenner C Rice; Jonathan L Katz
The partial opioid agonist, buprenorphine, protects against lethal effects of cocaine.
Drug and alcohol dependence 1991;27(2):177-84.
1991: D J Spear; Carles Muntaner; Steven R Goldberg; Jonathan L Katz
Methohexital and cocaine self-administration under fixed-ratio and second-order schedules.
Pharmacology, biochemistry, and behavior 1991;38(2):411-6.
1991: Jonathan L Katz; Jeffrey M Witkin
Behavioral effects of cocaine alone and in combination with selective dopamine antagonists in the squirrel monkey.
Psychopharmacology 1991;103(1):33-40.
1991: Jonathan L Katz; Lawrence G Sharpe; Jerome H Jaffe; E I Shores; Jeffrey M Witkin
Discriminative stimulus effects of inhaled cocaine in squirrel monkeys.
Psychopharmacology 1991;105(3):317-21.
1990: Jeffrey M Witkin; George A Ricaurte; Jonathan L Katz
Behavioral effects of N-methylamphetamine and N,N-dimethylamphetamine in rats and squirrel monkeys.
The Journal of pharmacology and experimental therapeutics 1990;253(2):466-74.
1990: Charles W Schindler; X Z Wu; Tsung-Ping Su; Steven R Goldberg; Jonathan L Katz
Enhanced sensitivity to behavioral effects of naltrexone in rats.
The Journal of pharmacology and experimental therapeutics 1990;252(1):8-14.
1989: Jeffrey M Witkin; Steven R Goldberg; Jonathan L Katz; Michael J Kuhar
Modulation of the lethal effects of cocaine by cholinomimetics.
Life sciences 1989;45(24):2295-301.
1989: Jeffrey M Witkin; Steven R Goldberg; Jonathan L Katz
Lethal effects of cocaine are reduced by the dopamine-1 receptor antagonist SCH 23390 but not by haloperidol.
Life sciences 1989;44(18):1285-91.
1989: K Takada; MD Swedberg; Steven R Goldberg; Jonathan L Katz
Discriminative stimulus effects of intravenous l-nicotine and nicotine analogs or metabolites in squirrel monkeys.
Psychopharmacology 1989;99(2):208-12.
1989: Jonathan L Katz
Interactions of clonidine and naloxone on schedule-controlled behavior in opioid-naive mice.
Psychopharmacology 1989;98(4):445-7.
1989: Jonathan L Katz
Two types of bias in psychophysical detection and recognition procedures: nonparametric indices and effects of drugs.
Psychopharmacology 1989;97(2):202-5.
1989: K Takada; T Suzuki; T Hagen; James M Cook; Jonathan L Katz
Behavioral effects of benzodiazepine antagonists in chlordiazepoxide tolerant and non-tolerant rats.
Life sciences 1989;44(4):289-99.
1988: Jonathan L Katz
Effects of drugs on stimulus control of behavior. III. Analysis of effects of pentobarbital and d-amphetamine.
The Journal of pharmacology and experimental therapeutics 1988;246(1):76-83.
1988: K Takada; T J Hagen; James M Cook; Steven R Goldberg; Jonathan L Katz
Discriminative stimulus effects of intravenous nicotine in squirrel monkeys.
Pharmacology, biochemistry, and behavior 1988;30(1):243-7.
1988: Jonathan L Katz; J A Prada; Steven R Goldberg
Effects of adenosine analogs alone and in combination with caffeine in the squirrel monkey.
Pharmacology, biochemistry, and behavior 1988;29(2):429-32.
1988: Charles W Schindler; Jonathan L Katz; Steven R Goldberg
The use of second-order schedules to study the influence of environmental stimuli on drug-seeking behavior.
NIDA research monograph 1988;84():180-95.
1987: Jack E Henningfield; R Nemeth-Coslett; Jonathan L Katz; Steven R Goldberg
Intravenous cocaine self-administration by human volunteers: second-order schedules of reinforcement.
NIDA research monograph 1987;76():266-73.